News and Comments

PERRIGO ACQUIRES ELAN

Prohost Biotech - Monday, July 29, 2013

Elan is Taken over by Perrigo in a transaction that involves cash and shares of Perrigo.  For the details of the transaction, the press release and the PDF presentation by the New Perrigo Prohost subscribers can click on TODAY'S HIGHLIGHTS at this Website. 

This transaction was predictable. Congratulation for Prohost subscribers who kept the stock even during the time when the stock had tumbled under tremendous pressure by the market evaluators.  

FORWARD-LOOKING: Material presented here is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock you should do your own research and reach your own conclusion. Further, these are our 'opinions' and we may be wrong. We may have positions in securities mentioned in this article. You should take this into consideration before acting on any advice given in this article. If this makes you uncomfortable, then do not listen to our thoughts and opinions. The contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision. Investing includes certain risks including loss of principal.


Comments
Post has no comments.
Post a Comment




Captcha Image

Trackback Link
http://www.prohostbiotech.com/BlogRetrieve.aspx?BlogID=8883&PostID=1086420&A=Trackback
Trackbacks
Post has no trackbacks.

Recent Postings


Archive


Tags

Gilead (GILD) ARGOS (ARGS) Cytokinetics (CYTK) AstraZeneca (AZN) RenenxBio (RGNX) Ziofpharm (ZIOP) Auspex (ASPX) Sequenom (SQNM) Bellicum (BLCM) HALOZYME (HALO) Velcade (bortezomib) Anacor (ANAC) Theravance (THRX) Valeant Pharmaceuticals International (VRX) Revlimid (lenolidamide) ABBVIE (ABBV) Vitae Pharmaceuticals (VTAE) GUARDIAN HEALTH Elan (ELN) ImmunoGen (IMGN) REGULUS (RGLS) SERES THERAPEUTICS (MCRB) Sarepta (SRPT) Human Longevity (HLI) Endometrial Cancer Advaxis (ADXS) Mirati Therapeutics (MRTX) Xoma (XOMA) Editas (EDIT) GlaxoSmithKline (GSK) Merck (MRK) Exelixis (EXEL) Ariad (ARIA) Seattle Genetics (SGEN) Roche (ROCHE) CRISPR Therapeutics (CRSP) Genentech Amgen (AMGN) Intermune (ITMN) Abbott Laboratories (ABT) Sanofi-Aventis (SAN) Spike Therapeutics (ONCE) Anadys (ANDS) Adaptimmune (ADAP) Agenus (AGEN) IDERA (IDRA) Prosensa (RNA) Theravance Bio Pharma (TBPH) Incyte (INCY) Vertex (VRTX) ISIS (ISIS) Idenix (IDIX) Agenus (AGEN Bristol-Myers Squibb (BMY) Dynavax (DVAX) Intercept (ICPT) JOUNCE THERAPEUTICS (JNCE) AERIE PHARMACEUTICALS CompuGen (CGEN) Aimmune Therapeutics (AIMT) ADVENTRIX (ANX) NANTKWEST (NK) Human Genome Sciences (HGSI) KITE (KITE) ACADIA (ACAD) VANDA (VNDA) Alnylam (ALNY) Benlysta (belimumab) Ionis (IONS) Zerenex Ocular Therapeutix (OCUL) Dendreon (DNDN) SYNTA (SNTA) Jazz Pharmaceuticals (JAZZ) JUNO (JUNO) Sangamo (SGMO) Galena (GALE) Multiple Myeloma NEKTAR (NKTR)) Herceptin NOVOCURE (NVCR) PTC Therapeutics (PTCT) CEMPRA (CEMP) ZALTRAP™ INNOVIVA (INVA) Sanofi (SNY) BIOMARIN (BMRN) Global Cell Therapeutics (GBT) Biocryst (BCRX) Rapamune Alder Biopharmaceuticals (ALDR) Telaprevir Ridaforolimus AGOS (ARGS) Illumina (ILMN) MODERNA Sanofi (SNA) C4 Therapeutics galapagos (GLPG) Onyx (ONXX) Regeneron (REGN) TOKAI (TKAOI) Micromet (MITI) Array Pharmaceuticals (ARRY) SUNESIS PHARMACEUTICALS (SNSS) Inovio (INO) Biogen Idec (BIIB) Roche (RHHBY) Intrexon (XON) Tysabri ARCA (ABIO) OSI (OSIP) Prolor Biotech (PBTH) PORTOLA (PTLA) KERYX (KERX) Pluristem (PSTI) Trastuzumab-DM1